2-naphthol has been researched along with rolipram in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, S; Chen, G; Chen, T; Fan, L; He, P; Li, J; Li, Q; Peng, Y; Ruan, W; Xu, H | 1 |
1 other study(ies) available for 2-naphthol and rolipram
| Article | Year |
|---|---|
Phosphodiesterase-4 inhibition confers a neuroprotective efficacy against early brain injury following experimental subarachnoid hemorrhage in rats by attenuating neuronal apoptosis through the SIRT1/Akt pathway.
Topics: Animals; Apoptosis; Benzamides; Brain Edema; Brain Injuries; Cyclic Nucleotide Phosphodiesterases, Type 4; Heterocyclic Compounds, 3-Ring; Male; Naphthols; Neuroprotective Agents; Phosphodiesterase 4 Inhibitors; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Rolipram; Sirtuin 1; Subarachnoid Hemorrhage | 2018 |